SCHEMBL4582468

SCHEMBL4582468

C[Si](C)(C)O[Si](C)(CCCNC(=O)CCc1ccccc1)O[Si](C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.63
KDM4E B2RXH2 1/20 0.63
HPGD P15428 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.57
GAA P10253 1/20 0.56
TSHR P16473 1/20 0.51
POLB P06746 1/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC2 Q92769 3/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC3 O15379 2/20 0.51
HDAC4 P56524 2/20 0.51
HDAC10 Q969S8 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC9 Q9UKV0 2/20 0.51
NCOR2 Q9Y618 2/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
KEAP1 Q14145 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8744900 0.79 HPGD (0.81) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL1093862 0.78 HPGD (0.91) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL17578483 0.78 TSHR (0.40) LMNAKDM4EL3MBTL1TSHRMEN1
SCHEMBL2584078 0.77 IDO1 (0.47) L3MBTL1MEN1KMT2A
SCHEMBL4582261 0.77 NAAA (0.56) LMNAHPGDGAAPOLBHDAC1
SCHEMBL2187602 0.77 HPGD (1.00) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL6290032 0.76 L3MBTL1 (0.72) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL9829299 0.76 LMNA (0.77) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL6289079 0.76 L3MBTL1 (0.72) LMNAKDM4EHPGDL3MBTL1GAA
SCHEMBL2186352 0.76 HDAC2 (0.72) LMNAKDM4EHPGDL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080317685-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and siloxane-containing arylalkyl benzoate amide compounds L'OREAL (FR) 2008-12-25 US disclosed
US-20080317685-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and siloxane-containing arylalkyl benzoate amide compounds L'OREAL (FR) 2008-12-25 US disclosed
EP-1925289-A2 Cosmetic composition containing a dibenzoylmethane derivative and a siloxanic benzoate arylalkyl amide derivative; method for photostabilising the dibenzoylmethane derivative L'Oréal (FR) 2008-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080317685-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and siloxane-containing arylalkyl benzoate amide compounds AADAC, DDT, CUTA LMNA 1962/4885KDM4E 759/4885HPGD 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.